International Business News - GTXI http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif Biopharmaceutical company GTx Inc. said Tuesday its second-quarter loss widened due to higher research and development expenses and administrative costs. http://www.ibtimes.com/articles/20080805/gtx-2q-loss-widens-on-r-d-administrative-costs.htm Tue, 05 Aug 2008 10:24:39 EDT Biopharmaceutical company GTx Inc. said Monday it is continuing a late-stage study of its experimental prostate cancer drug after completing a planned safety review. http://www.ibtimes.com/articles/20080728/gtx-study-continues-after-safety-review.htm Mon, 28 Jul 2008 08:25:45 EDT Among the stock activity stories for Friday, May 23, from AP Financial News: NEW YORK (AP)--Suntech Power Holdings Co. Ltd.'s American Depositary Shares rose Friday after the solar cell maker posted strong first-quarter results that easily beat Wall Street expectations. http://www.ibtimes.com/articles/20080523/movers-roundup-suntech-power-black-box.htm Fri, 23 May 2008 14:21:08 EDT Shares of biopharmaceutical company GTx Inc. fell Friday after the company said a late-stage trial of its prostate cancer drug candidate needs to continue, precluding an early filing with the Food & Drug Administration. http://www.ibtimes.com/articles/20080523/gtx-shares-fall-on-prostate-cancer-drug-trial.htm Fri, 23 May 2008 17:21:55 EDT Shares of biopharmaceutical company GTx Inc. dropped in Friday premarket trading after the company said a trial of its prostate cancer drug candidate Acadopene will continue, meaning that the drug has yet to meet effectiveness goals. http://www.ibtimes.com/articles/20080523/premarket-movers-gtxi-aapl-skil.htm Fri, 23 May 2008 09:26:11 EDT Biopharmaceutical company GTx Inc. said Friday an independent group recommended that a late-stage trial of a prostate cancer drug continue after reviewing an interim analysis of the drug's effectiveness. http://www.ibtimes.com/articles/20080523/gtx-says-prostate-cancer-drug-trial-will-continue.htm Fri, 23 May 2008 08:22:21 EDT Among the earnings stories for Monday, May 12, from AP Financial News: NEW YORK (AP) _ Imax Corp., a maker of large-screen movie systems, said Monday its fiscal first-quarter loss widened on increased expenses. http://www.ibtimes.com/articles/20080512/earnings-roundup-imax-holly.htm Mon, 12 May 2008 11:05:24 EDT Biopharmaceutical company GTx Inc. said Monday it expected to report a full-year loss between $52 million and $62 million _ larger than the $44.7 million loss expected by Wall Street. http://www.ibtimes.com/articles/20080512/gtx-forecasts-larger-than-expected-full-year-loss.htm Mon, 12 May 2008 08:26:17 EDT Biopharmaceutical company GTx Inc. said Monday its first-quarter loss widened due to higher research and development expenses and administrative costs. http://www.ibtimes.com/articles/20080512/gtx-1q-loss-widens-on-higher-research-and-development-costs.htm Mon, 12 May 2008 08:09:57 EDT Shares of GTX Inc. are rising after Rodman & Renshaw initiated positive coverage on the biotechnology company, pointing out the market potential of several men's health treatments under development. http://www.ibtimes.com/articles/20080325/gtx-shares-rise-on-analyst-outlook.htm Tue, 25 Mar 2008 13:52:38 EDT Shares of GTx Inc. skyrocketed Monday after the company reported its experimental treatment toremifene citrate met its main goals in a late-stage prostate cancer trial and a Goldman Sachs analyst raised her price target. http://www.ibtimes.com/articles/20080225/gtx-soars-on-late-stage-cancer-study.htm Mon, 25 Feb 2008 18:25:40 EST Shares of GTX Inc. skyrocketed Monday after the company reported its experimental treatment toremifene citrate met its main goals in a late-stage trial in patients with advanced prostate cancer. http://www.ibtimes.com/articles/20080225/gtx-soars-on-late-stage-trial-results.htm Mon, 25 Feb 2008 08:37:10 EST Biopharmaceutical company GTX Inc. said Tuesday its loss widened in the fourth quarter, as costs and expenses rose. For the quarter ended Dec. 31, the company lost $12.8 million, or 36 cents per share, compared with a loss of $4.7 million, or 15 cents per share, a year ago. Total costs and expenses rose to $15.8 million from $10.3 million. http://www.ibtimes.com/articles/20080219/gtx-4q-loss-widens.htm Tue, 19 Feb 2008 07:42:07 EST